Thierry Boon

This inventor holds 13 USPTO granted patents and 1 EPO patent. Top assignees: Ludwig Institute for Cancer Research Limited, Smithkline Beecham Biologicals S.a.. Active years: 1994-2024.

USPTO Granted Patents = 13

% Patents Active = 84.6

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 218(Granted Patents)

Location History:

Brussles, BE (2009)
Brussels, BE (1994 - 2024)

Company Filing History:

12 out of 529

Ludwig Institute for Cancer Research Limited

patents

1 out of 75

Smithkline Beecham Biologicals S.a.

patents

Years Active: 1994-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11957751 - TGF-β1 specific antibodies and methods and uses thereof (2024-04-16),

2. 10947303 - TGF-ß1 specific antibodies and methods and uses thereof (2021-03-16),

3. 10035851 - TGF-β1 specific antibodies and methods and uses thereof (2018-07-31),

4. 9518112 - TGF-β1 specific antibodies and methods and uses thereof (2016-12-13),

5. 7923534 - Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 (2011-04-12),

6. 7547439 - Tumor rejection antigens (2009-06-16),

7. 7041502 - Isolated peptides which bind to HLA-B18 molecules and uses thereof (2006-05-09),

8. 6488932 - Method for treating cancer by administering MAGE-derived peptides (2002-12-03),

9. 6375945 - Adjuvant compositions for vaccines (2002-04-23),

10. 6034214 - Isolated nonapeptides which bind to HLA molecules and provoke lysis by (2000-03-07),

11. 5925729 - Tumor rejection antigen precursors, tumor rejection antigens and uses (1999-07-20),

12. 5405940 - Isolated nonapeptides derived from MAGE genes and uses thereof (1995-04-11),

13. 5342774 - Nucleotide sequence encoding the tumor rejection antigen precursor, (1994-08-30),

Title: Thierry Boon: Pioneering Inventor from Brussels

Introduction: Thierry Boon is a renowned inventor hailing from Brussels, Belgium, known for his groundbreaking contributions to the field of innovation.

Latest Patents: Boon's latest patents include advancements in biotechnology, particularly in the development of novel cancer treatment methods and diagnostic tools.

Career Highlights: With a career spanning over three decades, Boon has established himself as a leading figure in the world of inventors, holding numerous patents in various technological domains.

Collaborations: Throughout his career, Boon has collaborated with top research institutions and universities worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Thierry Boon's relentless pursuit of innovation and his significant contributions to the field have solidified his position as a trailblazing inventor in the global landscape of technological advancements.